Hugo_Symbol Entrez_Gene_Id Center NCBI_Build Chromosome Start_position End_position Strand Variant_Classification Variant_Type Reference_Allele Tumor_Seq_Allele1 Tumor_Seq_Allele2 dbSNP_RS dbSNP_Val_Status Tumor_Sample_Barcode Matched_Norm_Sample_Barcode Match_Norm_Seq_Allele1 Match_Norm_Seq_Allele2 Tumor_Validation_Allele1 Tumor_Validation_Allele2 Match_Norm_Validation_Allele1 Match_Norm_Validation_Allele2 Verification_Status Validation_Status Mutation_Status Sequencing_Phase Sequence_Source Validation_Method Score BAM_file Sequencer Tumor_Sample_UUID Matched_Norm_Sample_UUID Genome_Change Annotation_Transcript Transcript_Strand Transcript_Exon Transcript_Position cDNA_Change Codon_Change Protein_Change Other_Transcripts Refseq_mRNA_Id Refseq_prot_Id SwissProt_acc_Id SwissProt_entry_Id Description UniProt_AApos UniProt_Region UniProt_Site UniProt_Natural_Variations UniProt_Experimental_Info GO_Biological_Process GO_Cellular_Component GO_Molecular_Function COSMIC_overlapping_mutations COSMIC_fusion_genes COSMIC_tissue_types_affected COSMIC_total_alterations_in_gene Tumorscape_Amplification_Peaks Tumorscape_Deletion_Peaks TCGAscape_Amplification_Peaks TCGAscape_Deletion_Peaks DrugBank ref_context gc_content CCLE_ONCOMAP_overlapping_mutations CCLE_ONCOMAP_total_mutations_in_gene CGC_Mutation_Type CGC_Translocation_Partner CGC_Tumor_Types_Somatic CGC_Tumor_Types_Germline CGC_Other_Diseases DNARepairGenes_Role FamilialCancerDatabase_Syndromes MUTSIG_Published_Results OREGANNO_ID OREGANNO_Values t_alt_count t_ref_count validation_alt_allele validation_method validation_status validation_tumor_sample pox qox pox_cutoff isArtifactMode oxoGCut PCK1 5105 broad.mit.edu 37 20 56139236 56139236 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr20:56139236G>A ENST00000319441.4 + 7 1137 c.973G>A c.(973-975)Gcc>Acc p.A325T PCK1_ENST00000543666.1_Missense_Mutation_p.A8T|PCK1_ENST00000535860.1_Missense_Mutation_p.A193T NM_002591.3 NP_002582.3 P35558 PCKGC_HUMAN phosphoenolpyruvate carboxykinase 1 (soluble) 325 gluconeogenesis|glucose homeostasis|glycerol biosynthetic process from pyruvate|response to insulin stimulus cytosol|nucleus carboxylic acid binding|GTP binding|magnesium ion binding|manganese ion binding|phosphoenolpyruvate carboxykinase (GTP) activity p.A325T(1) endometrium(2)|kidney(1)|large_intestine(4)|liver(2)|lung(19)|pancreas(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(3) 34 Lung NSC(12;0.000764)|all_lung(29;0.00264)|Melanoma(10;0.242) BRCA - Breast invasive adenocarcinoma(13;9.88e-12)|Epithelial(14;3.41e-08)|all cancers(14;2.13e-07) TCATTTAAGGGCCATCAACCC 0.448000 9 40 0 0 1 0 0 RYR1 6261 broad.mit.edu 37 19 38995497 38995497 + Missense_Mutation SNP A A G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:38995497A>G ENST00000355481.4 + 51 8308 c.8177A>G c.(8176-8178)aAg>aGg p.K2726R RYR1_ENST00000360985.3_Missense_Mutation_p.K2726R|RYR1_ENST00000359596.3_Missense_Mutation_p.K2726R NM_000540.2|NM_001042723.1 NP_000531.2|NP_001036188.1 P21817 RYR1_HUMAN ryanodine receptor 1 (skeletal) 2726 6 X approximate repeats. muscle contraction|release of sequestered calcium ion into cytosol|response to caffeine|response to hypoxia cell cortex|cytosol|I band|integral to plasma membrane|junctional sarcoplasmic reticulum membrane|smooth endoplasmic reticulum|terminal cisterna calcium ion binding|calmodulin binding|receptor activity|ryanodine-sensitive calcium-release channel activity NS(4)|autonomic_ganglia(2)|breast(3)|central_nervous_system(5)|endometrium(26)|haematopoietic_and_lymphoid_tissue(3)|kidney(34)|large_intestine(42)|liver(1)|lung(106)|ovary(11)|pancreas(5)|prostate(9)|skin(12)|stomach(11)|upper_aerodigestive_tract(4)|urinary_tract(7) 285 all_cancers(60;7.91e-06) Lung(45;0.00172)|LUSC - Lung squamous cell carcinoma(53;0.00272) Dantrolene(DB01219) GCAGAGAAAAAGGCCACAGTG 0.597000 3 51 0 0 1 0 0 VPS13D 55187 broad.mit.edu 37 1 12439544 12439544 + Missense_Mutation SNP A A G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr1:12439544A>G ENST00000358136.3 + 57 11214 c.11084A>G c.(11083-11085)tAc>tGc p.Y3695C VPS13D_ENST00000496628.1_3'UTR|VPS13D_ENST00000356315.4_Missense_Mutation_p.Y3670C NM_015378.2 NP_056193.2 Q5THJ4 VP13D_HUMAN vacuolar protein sorting 13 homolog D (S. cerevisiae) 3694 protein localization NS(1)|breast(6)|endometrium(11)|haematopoietic_and_lymphoid_tissue(2)|kidney(13)|large_intestine(28)|lung(44)|ovary(5)|pancreas(1)|prostate(8)|skin(4)|upper_aerodigestive_tract(3)|urinary_tract(4) 130 Ovarian(185;0.249) Lung NSC(185;4.08e-05)|all_lung(284;4.55e-05)|Renal(390;0.000147)|Colorectal(325;0.00058)|Breast(348;0.00093)|Ovarian(437;0.00965)|Hepatocellular(190;0.0202)|Myeloproliferative disorder(586;0.0255) UCEC - Uterine corpus endometrioid carcinoma (279;0.0327)|Colorectal(212;4.63e-06)|BRCA - Breast invasive adenocarcinoma(304;0.000289)|COAD - Colon adenocarcinoma(227;0.000801)|Kidney(185;0.00216)|KIRC - Kidney renal clear cell carcinoma(229;0.00544)|STAD - Stomach adenocarcinoma(313;0.012)|READ - Rectum adenocarcinoma(331;0.0476)|Lung(427;0.209) TTTTCCAGATACGAGCCACTG 0.498000 36 53 0 0 1 0 0 C6orf118 168090 broad.mit.edu 37 6 165715396 165715396 + Missense_Mutation SNP A A G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:165715396A>G ENST00000543069.1 - 2 684 c.103T>C c.(103-105)Tcc>Ccc p.S35P C6orf118_ENST00000230301.8_Missense_Mutation_p.S139P Q5T5N4 CF118_HUMAN chromosome 6 open reading frame 118 139 breast(1)|kidney(2)|large_intestine(9)|liver(1)|lung(21)|prostate(2)|skin(3)|upper_aerodigestive_tract(1) 40 Breast(66;6.27e-05)|Ovarian(120;0.0228)|Prostate(117;0.0906)|all_neural(5;0.157) OV - Ovarian serous cystadenocarcinoma(33;3.23e-18)|BRCA - Breast invasive adenocarcinoma(81;3.11e-06)|GBM - Glioblastoma multiforme(31;0.000313) GAAGTGTGGGAAAGAGAGGCC 0.627000 17 103 0 0 1 0 0 ZC3H4 23211 broad.mit.edu 37 19 47593321 47593321 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:47593321G>A ENST00000253048.5 - 5 655 c.618C>T c.(616-618)ggC>ggT p.G206G ZC3H4_ENST00000594019.1_5'UTR NM_015168.1 NP_055983.1 Q9UPT8 ZC3H4_HUMAN zinc finger CCCH-type containing 4 206 nucleic acid binding|zinc ion binding NS(1)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(6)|lung(13)|ovary(4)|prostate(2)|skin(7)|upper_aerodigestive_tract(1) 41 all_cancers(25;3.3e-08)|all_epithelial(76;2.28e-06)|all_lung(116;7.86e-06)|Lung NSC(112;2.31e-05)|all_neural(266;0.026)|Ovarian(192;0.0392)|Breast(70;0.0889) OV - Ovarian serous cystadenocarcinoma(262;5.76e-05)|all cancers(93;7.69e-05)|Epithelial(262;0.00354)|GBM - Glioblastoma multiforme(486;0.0372) CCTCCTCGTCGCCCTCATATT 0.577000 39 72 0 0 1 0 0 PPIG 9360 broad.mit.edu 37 2 170488410 170488410 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:170488410G>A ENST00000260970.3 + 11 1116 c.896G>A c.(895-897)aGg>aAg p.R299K PPIG_ENST00000462903.1_Missense_Mutation_p.R299K|PPIG_ENST00000482772.1_3'UTR|PPIG_ENST00000409714.3_Missense_Mutation_p.R284K|PPIG_ENST00000448752.2_Missense_Mutation_p.R299K NM_004792.2 NP_004783.2 Q13427 PPIG_HUMAN peptidylprolyl isomerase G (cyclophilin G) 299 protein folding|RNA splicing nuclear matrix|nuclear speck cyclosporin A binding|peptidyl-prolyl cis-trans isomerase activity NS(2)|breast(2)|central_nervous_system(2)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(8)|liver(1)|lung(17)|ovary(2)|stomach(1)|urinary_tract(1) 43 L-Proline(DB00172) gagaaggaaaggaaaaacaga 0.373000 14 16 0 0 1 0 0 ITPR2 3709 broad.mit.edu 37 12 26985668 26985668 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr12:26985668G>A ENST00000381340.3 - 1 463 c.47C>T c.(46-48)tCc>tTc p.S16F ITPR2_ENST00000242737.5_Missense_Mutation_p.S16F NM_002223.2 NP_002214.2 Q14571 ITPR2_HUMAN inositol 1,4,5-trisphosphate receptor, type 2 16 activation of phospholipase C activity|energy reserve metabolic process|nerve growth factor receptor signaling pathway|platelet activation|regulation of insulin secretion|response to hypoxia integral to membrane|plasma membrane enriched fraction|platelet dense tubular network membrane|sarcoplasmic reticulum membrane calcium ion transmembrane transporter activity|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity ETV6/ITPR2(2) biliary_tract(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(2)|kidney(16)|large_intestine(20)|liver(1)|lung(51)|ovary(5)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(5)|urinary_tract(3) 125 Colorectal(261;0.0847) CGCGTACAGGGACACGATGTC 0.622000 27 123 0 0 1 0 0 KIF6 221458 broad.mit.edu 37 6 39513460 39513460 + Missense_Mutation SNP C C G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:39513460C>G ENST00000287152.7 - 11 1280 c.1186G>C c.(1186-1188)Gaa>Caa p.E396Q KIF6_ENST00000373213.4_Missense_Mutation_p.E235Q|KIF6_ENST00000373215.3_Missense_Mutation_p.E396Q|KIF6_ENST00000373216.3_Missense_Mutation_p.E396Q|KIF6_ENST00000538893.1_Missense_Mutation_p.E396Q NM_145027.4 NP_659464.3 Q6ZMV9 KIF6_HUMAN kinesin family member 6 396 microtubule-based movement cytoplasm|microtubule ATP binding|microtubule motor activity|protein binding breast(2)|central_nervous_system(1)|endometrium(1)|kidney(16)|large_intestine(8)|lung(15)|ovary(1)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1) 52 ATTAGTTTTTCCAGCCTAAAA 0.338000 3 57 0 0 1 0 0 ZEB2 9839 broad.mit.edu 37 2 145147369 145147369 + Silent SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:145147369T>C ENST00000558170.2 - 10 4478 c.3294A>G c.(3292-3294)aaA>aaG p.K1098K ZEB2_ENST00000303660.4_Silent_p.K1098K|ZEB2_ENST00000539609.3_Silent_p.K1074K|ZEB2_ENST00000409487.3_Silent_p.K1098K NM_014795.3 NP_055610.1 O60315 ZEB2_HUMAN zinc finger E-box binding homeobox 2 1098 Glu-rich (acidic). cytoplasm|nucleolus phosphatase regulator activity|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|SMAD binding|zinc ion binding breast(3)|central_nervous_system(1)|cervix(2)|endometrium(7)|kidney(6)|large_intestine(23)|lung(45)|ovary(5)|pancreas(2)|prostate(6)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(3) 107 BRCA - Breast invasive adenocarcinoma(221;0.112) CCAAGTGCCCTTTCTCGCGCG 0.617000 25 60 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7577570 7577570 + Missense_Mutation SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr17:7577570C>T ENST00000420246.2 - 7 843 c.711G>A c.(709-711)atG>atA p.M237I TP53_ENST00000359597.4_Missense_Mutation_p.M237I|TP53_ENST00000455263.2_Missense_Mutation_p.M237I|TP53_ENST00000413465.2_Missense_Mutation_p.M237I|TP53_ENST00000445888.2_Missense_Mutation_p.M237I|TP53_ENST00000269305.4_Missense_Mutation_p.M237I NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 237 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity). M -> I (in LFS; germline mutation and in sporadic cancers; somatic mutation).|M -> K (in sporadic cancers; somatic mutation).|M -> L (in sporadic cancers; somatic mutation).|M -> R (in sporadic cancers; somatic mutation).|M -> T (in sporadic cancers; somatic mutation).|M -> V (in sporadic cancers; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.M237I(109)|p.0?(8)|p.?(5)|p.M144I(4)|p.M237_N239delMCN(4)|p.Y236_M237delYM(1)|p.H233fs*6(1)|p.M144_N146delMCN(1)|p.Y236_M243delYMCNSSCM(1)|p.C238fs*2(1)|p.V225fs*23(1)|p.M237_C238insX(1)|p.H233_C242del10(1)|p.M237fs*1(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) AACTGTTACACATGTAGTTGT 0.567000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 35 51 0 0 1 0 0 NFATC1 4772 broad.mit.edu 37 18 77227575 77227575 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr18:77227575C>T ENST00000253506.5 + 8 2454 c.2085C>T c.(2083-2085)ccC>ccT p.P695P NFATC1_ENST00000545796.1_Silent_p.P223P|NFATC1_ENST00000591814.1_Silent_p.P695P|NFATC1_ENST00000397790.2_Silent_p.P223P|NFATC1_ENST00000329101.4_Silent_p.P682P|NFATC1_ENST00000592223.1_Silent_p.P682P|NFATC1_ENST00000318065.5_Silent_p.P682P|NFATC1_ENST00000542384.1_Silent_p.P695P|NFATC1_ENST00000427363.2_Silent_p.P695P|NFATC1_ENST00000587635.1_3'UTR|NFATC1_ENST00000586434.1_Silent_p.P682P NM_006162.3 NP_006153.2 O95644 NFAC1_HUMAN nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 695 intracellular signal transduction|positive regulation of transcription, DNA-dependent|transcription from RNA polymerase II promoter cytoplasm|nucleus FK506 binding|protein binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding NS(2)|breast(1)|endometrium(7)|kidney(1)|large_intestine(4)|lung(17)|ovary(2)|prostate(4)|skin(1)|soft_tissue(1) 40 Esophageal squamous(42;0.0157)|Melanoma(33;0.144) OV - Ovarian serous cystadenocarcinoma(15;3.73e-07)|BRCA - Breast invasive adenocarcinoma(31;0.0257) CCTACCTTCCCGCCAACGGTA 0.532000 24 46 0 0 1 0 0 ABCB1 5243 broad.mit.edu 37 7 87214993 87214993 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:87214993G>A ENST00000265724.3 - 5 538 c.121C>T c.(121-123)Cgc>Tgc p.R41C ABCB1_ENST00000543898.1_Missense_Mutation_p.R41C NM_000927.4 NP_000918.2 P08183 MDR1_HUMAN ATP-binding cassette, sub-family B (MDR/TAP), member 1 41 G2/M transition of mitotic cell cycle|stem cell proliferation apical plasma membrane|cell surface|Golgi membrane|integral to membrane|intercellular canaliculus|membrane fraction ATP binding|protein binding|xenobiotic-transporting ATPase activity NS(1)|breast(6)|central_nervous_system(2)|endometrium(14)|kidney(9)|large_intestine(14)|lung(48)|ovary(4)|prostate(6)|skin(6)|upper_aerodigestive_tract(1) 111 Esophageal squamous(14;0.00164) Adenosine triphosphate(DB00171)|Alfentanil(DB00802)|Arsenic trioxide(DB01169)|Atazanavir(DB01072)|Carvedilol(DB01136)|Colchicine(DB01394)|Cyclosporine(DB00091)|Daunorubicin(DB00694)|Dipyridamole(DB00975)|Estramustine(DB01196)|Flupenthixol(DB00875)|Imatinib(DB00619)|Itraconazole(DB01167)|Nicardipine(DB00622)|Propafenone(DB01182)|Quinacrine(DB01103)|Quinidine(DB00908)|Ranolazine(DB00243)|Rifampin(DB01045)|Roxithromycin(DB00778)|Saquinavir(DB01232)|Tamoxifen(DB00675)|Vinblastine(DB00570) TTTGAATAGCGAAACTAAAAA 0.378000 18 35 0 0 1 0 0 LIPG 9388 broad.mit.edu 37 18 47107968 47107968 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr18:47107968T>C ENST00000261292.4 + 6 1255 c.977T>C c.(976-978)aTg>aCg p.M326T LIPG_ENST00000580036.1_Missense_Mutation_p.M326T|LIPG_ENST00000577628.1_Missense_Mutation_p.M362T|LIPG_ENST00000427224.2_Missense_Mutation_p.M252T NM_006033.2 NP_006024.1 Q9Y5X9 LIPE_HUMAN lipase, endothelial 326 Heparin-binding (By similarity). cholesterol homeostasis|high-density lipoprotein particle remodeling|phospholipid catabolic process|phospholipid homeostasis|positive regulation of cholesterol transport|positive regulation of high-density lipoprotein particle clearance|reverse cholesterol transport extracellular space heparin binding|lipoprotein lipase activity|phospholipase A1 activity|protein binding|triglyceride lipase activity autonomic_ganglia(1)|breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|lung(6)|ovary(1)|prostate(2)|skin(2) 18 GCCAAGAAAATGAGGAACAAG 0.493000 62 77 0 0 1 0 0 MYPOP 339344 broad.mit.edu 37 19 46394511 46394511 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:46394511C>T ENST00000322217.5 - 3 656 c.570G>A c.(568-570)caG>caA p.Q190Q NM_001012643.2 NP_001012661.1 Q86VE0 MYPOP_HUMAN Myb-related transcription factor, partner of profilin 190 Pro-rich. nucleus DNA binding large_intestine(2)|lung(1)|skin(1) 4 AGCCCCCTTCCTGGGGAGTGC 0.677000 6 0 0 0 1 0 0 PCDHGA12 0 broad.mit.edu 37 5 140812212 140812212 + Missense_Mutation SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr5:140812212C>T ENST00000252085.3 + 1 2028 c.1886C>T c.(1885-1887)gCg>gTg p.A629V PCDHGA4_ENST00000571252.1_Intron|PCDHGB3_ENST00000576222.1_Intron|PCDHGA2_ENST00000394576.2_Intron|PCDHGB1_ENST00000523390.1_Intron|PCDHGB2_ENST00000522605.1_Intron|PCDHGA3_ENST00000253812.6_Intron|PCDHGA9_ENST00000573521.1_Intron|PCDHGB4_ENST00000519479.1_Intron|PCDHGA7_ENST00000518325.1_Intron|PCDHGA11_ENST00000518882.1_Intron|PCDHGA5_ENST00000518069.1_Intron|PCDHGA1_ENST00000517417.1_Intron|PCDHGA11_ENST00000398587.2_Intron|PCDHGB7_ENST00000398594.2_Intron|PCDHGA8_ENST00000398604.2_Intron|PCDHGA10_ENST00000398610.2_Intron|PCDHGA6_ENST00000517434.1_Intron|PCDHGB6_ENST00000520790.1_Intron NM_003735.2|NM_032094.1 NP_003726.1|NP_115265.1 breast(2)|cervix(1)|endometrium(7)|kidney(1)|large_intestine(10)|lung(23)|ovary(5)|pancreas(1)|prostate(1)|skin(6)|upper_aerodigestive_tract(1) 58 KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191) GTGCGCACGGCGCGAGCCCTG 0.687000 12 47 0 0 1 0 0 ZNF57 126295 broad.mit.edu 37 19 2917793 2917793 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:2917793T>C ENST00000306908.5 + 4 1322 c.1174T>C c.(1174-1176)Tat>Cat p.Y392H ZNF57_ENST00000523428.1_Missense_Mutation_p.Y360H|AC006277.2_ENST00000520090.2_RNA NM_173480.2 NP_775751.1 Q68EA5 ZNF57_HUMAN zinc finger protein 57 392 regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding endometrium(1)|kidney(2)|large_intestine(5)|lung(2)|ovary(1)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1) 18 UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|OV - Ovarian serous cystadenocarcinoma(105;1.09e-113)|Epithelial(107;3.79e-112)|all cancers(105;1.67e-104)|BRCA - Breast invasive adenocarcinoma(158;0.00136)|GBM - Glioblastoma multiforme(1328;0.00161)|STAD - Stomach adenocarcinoma(1328;0.18) AGAGCAGCTCTATAAATGTGA 0.438000 4 75 0 0 1 0 0 OR5H1 26341 broad.mit.edu 37 3 97852349 97852349 + Missense_Mutation SNP C C G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr3:97852349C>G ENST00000354565.2 + 1 808 c.808C>G c.(808-810)Caa>Gaa p.Q270E RP11-343D2.11_ENST00000508964.1_RNA NM_001005338.1 NP_001005338.1 A6NKK0 OR5H1_HUMAN olfactory receptor, family 5, subfamily H, member 1 270 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity breast(1)|endometrium(7)|kidney(8)|large_intestine(3)|lung(13)|ovary(1)|skin(1) 34 AGCAGATGATCAAGATATGGT 0.428000 39 37 0 0 1 0 0 APOB 338 broad.mit.edu 37 2 21230555 21230555 + Nonsense_Mutation SNP A A C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:21230555A>C ENST00000233242.1 - 26 9312 c.9185T>G c.(9184-9186)tTa>tGa p.L3062* NM_000384.2 NP_000375.2 P04114 APOB_HUMAN apolipoprotein B 3062 cholesterol homeostasis|cholesterol metabolic process|leukocyte migration|low-density lipoprotein particle clearance|low-density lipoprotein particle remodeling|platelet activation|positive regulation of cholesterol storage|positive regulation of macrophage derived foam cell differentiation|receptor-mediated endocytosis|response to virus chylomicron remnant|clathrin-coated endocytic vesicle membrane|endoplasmic reticulum lumen|endoplasmic reticulum membrane|endosome lumen|endosome membrane|intermediate-density lipoprotein particle|low-density lipoprotein particle|mature chylomicron|microsome|plasma membrane|very-low-density lipoprotein particle cholesterol transporter activity|enzyme binding|heparin binding|low-density lipoprotein particle receptor binding|phospholipid binding|protein heterodimerization activity NS(5)|autonomic_ganglia(1)|breast(6)|central_nervous_system(4)|cervix(3)|endometrium(19)|kidney(10)|large_intestine(63)|liver(5)|lung(125)|ovary(16)|pancreas(1)|prostate(5)|skin(31)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(6) 305 Acute lymphoblastic leukemia(172;0.155)|all_hematologic(175;0.215) Atorvastatin(DB01076) TGTTAACCTTAATGGAAAACG 0.408000 4 63 0 0 1 0 0 FGF3 2248 broad.mit.edu 37 11 69631175 69631175 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:69631175C>T ENST00000334134.2 - 2 327 c.237G>A c.(235-237)acG>acA p.T79T NM_005247.2 NP_005238.1 P11487 FGF3_HUMAN fibroblast growth factor 3 79 fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|negative regulation of cardiac muscle tissue development|positive regulation of cell division|positive regulation of cell proliferation extracellular region growth factor activity p.T79T(1) endometrium(1)|kidney(1)|large_intestine(1)|lung(6)|ovary(1)|prostate(2)|urinary_tract(1) 13 LUSC - Lung squamous cell carcinoma(11;5.05e-15)|STAD - Stomach adenocarcinoma(18;0.0278) CCTCCACTGCCGTTATCTCCA 0.622000 4 95 0 0 1 0 0 DOCK4 9732 broad.mit.edu 37 7 111617325 111617325 + Missense_Mutation SNP T T A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:111617325T>A ENST00000428084.1 - 8 835 c.563A>T c.(562-564)cAt>cTt p.H188L DOCK4_ENST00000476846.1_5'UTR|DOCK4_ENST00000437633.1_Missense_Mutation_p.H188L Q8N1I0 DOCK4_HUMAN dedicator of cytokinesis 4 188 cell chemotaxis cytosol|endomembrane system|membrane|stereocilium GTP binding|guanyl-nucleotide exchange factor activity|PDZ domain binding|Rac GTPase activator activity|Rac GTPase binding|receptor tyrosine kinase binding|SH3 domain binding NS(1)|breast(1)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(4)|kidney(4)|large_intestine(13)|lung(31)|ovary(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(4) 72 Acute lymphoblastic leukemia(1;0.0441) TTTCTTCCGATGTCGATGTTC 0.502000 10 5 0 0 1 0 0 C11orf65 160140 broad.mit.edu 37 11 108256655 108256655 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:108256655T>C ENST00000525729.1 - 6 701 c.632A>G c.(631-633)aAc>aGc p.N211S C11orf65_ENST00000529391.1_Missense_Mutation_p.N260S|C11orf65_ENST00000526725.1_Intron|C11orf65_ENST00000393084.1_Missense_Mutation_p.N260S Q8NCR3 CK065_HUMAN chromosome 11 open reading frame 65 260 endometrium(1)|large_intestine(3)|lung(4)|ovary(2) 10 all_cancers(61;1.38e-11)|all_epithelial(67;3.16e-07)|Melanoma(852;2.55e-06)|Acute lymphoblastic leukemia(157;3.95e-05)|all_hematologic(158;0.00014)|Breast(348;0.0258)|all_neural(303;0.072) Epithelial(105;8.21e-06)|BRCA - Breast invasive adenocarcinoma(274;1.01e-05)|all cancers(92;0.000189)|Colorectal(284;0.114)|OV - Ovarian serous cystadenocarcinoma(223;0.144) ACCTTTGAAGTTAGCCGAAGA 0.333000 13 197 0 0 1 0 0 PBX2 5089 broad.mit.edu 37 6 32157564 32157564 + Silent SNP C C A rs151067717 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:32157564C>A ENST00000375050.4 - 1 399 c.129G>T c.(127-129)ggG>ggT p.G43G NM_002586.4 NP_002577.2 P40425 PBX2_HUMAN pre-B-cell leukemia homeobox 2 43 transcription factor binding endometrium(1)|kidney(1)|lung(9)|ovary(1)|prostate(2) 14 CTCCCGGGACCCCCCCGCTAC 0.711000 32 55 3.62531e-18 3.80073e-18 1 1 0 C12orf63 0 broad.mit.edu 37 12 97151344 97151344 + Missense_Mutation SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr12:97151344C>T ENST00000524981.3 + 25 3371 c.3371C>T c.(3370-3372)tCa>tTa p.S1124L Q6ZTY8 CL063_HUMAN 1098 p.S1098*(1) breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|kidney(1)|large_intestine(5)|lung(26)|ovary(1)|prostate(2)|skin(11)|stomach(2) 54 ATAAAAATTTCAGGATCACCA 0.303000 6 15 0 0 1 0 0 IDH1 3417 broad.mit.edu 37 2 209113113 209113113 + Missense_Mutation SNP G G T rs121913499 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:209113113G>T ENST00000415913.1 - 4 775 c.394C>A c.(394-396)Cgt>Agt p.R132S IDH1_ENST00000446179.1_Missense_Mutation_p.R132S|IDH1_ENST00000345146.2_Missense_Mutation_p.R132S O75874 IDHC_HUMAN isocitrate dehydrogenase 1 (NADP+), soluble 132 R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate). 2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle cytosol|peroxisomal matrix isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity p.R132C(446)|p.R132G(125)|p.R132S(106)|p.G131_R132>VL(1)|p.R132V(1) NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1) 4887 Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136) TAAGCATGACGACCTATGATG 0.398000 Mis gliobastoma 47 45 2.73361e-28 2.91287e-28 1 1 0 SUZ12P 0 broad.mit.edu 37 17 29061941 29061941 + RNA SNP T T C rs112064181 by1000genomes TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr17:29061941T>C ENST00000582557.1 + 0 861 TAGATTTCTTTGAACTCGGAA 0.303000 5 84 0 0 1 0 0 CLUL1 27098 broad.mit.edu 37 18 618009 618009 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr18:618009G>A ENST00000581619.1 + 2 931 c.84G>A c.(82-84)ccG>ccA p.P28P CLUL1_ENST00000400606.2_Silent_p.P3P|CLUL1_ENST00000580436.1_3'UTR|CLUL1_ENST00000540035.1_Silent_p.P55P|CLUL1_ENST00000338387.7_Silent_p.P3P|CLUL1_ENST00000579494.1_Silent_p.P3P Q15846 CLUL1_HUMAN clusterin-like 1 (retinal) 3 cell death extracellular region NS(1)|breast(1)|endometrium(5)|large_intestine(5)|liver(2)|lung(7)|ovary(2)|skin(1) 24 ACATGAAGCCGCCACTCTTGG 0.448000 5 34 0 0 1 0 0 XIAP 331 broad.mit.edu 37 X 123034427 123034427 + Missense_Mutation SNP A A G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chrX:123034427A>G ENST00000371199.3 + 6 1483 c.1184A>G c.(1183-1185)gAa>gGa p.E395G XIAP_ENST00000468691.1_3'UTR|XIAP_ENST00000355640.3_Missense_Mutation_p.E395G|XIAP_ENST00000434753.3_Missense_Mutation_p.E395G NM_001167.3 NP_001158.2 P98170 XIAP_HUMAN X-linked inhibitor of apoptosis 395 anti-apoptosis|apoptosis|induction of apoptosis by intracellular signals|response to DNA damage stimulus cytosol caspase inhibitor activity|ligase activity|protein binding|zinc ion binding breast(2)|endometrium(3)|kidney(3)|large_intestine(2)|lung(12)|ovary(3) 25 ATAATGGAGGAAAAAATTCAG 0.368000 X-linked Lymphoproliferative syndrome 31 5 0 0 1 0 0 SDK1 221935 broad.mit.edu 37 7 4185446 4185446 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:4185446G>A ENST00000404826.2 + 29 4460 c.4321G>A c.(4321-4323)Gac>Aac p.D1441N SDK1_ENST00000389531.3_Missense_Mutation_p.D1441N NM_152744.3 NP_689957.3 Q7Z5N4 SDK1_HUMAN sidekick cell adhesion molecule 1 1441 Fibronectin type-III 8. cell adhesion integral to membrane NS(1)|breast(6)|central_nervous_system(3)|cervix(1)|endometrium(13)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(42)|lung(55)|ovary(4)|pancreas(1)|prostate(4)|skin(6)|upper_aerodigestive_tract(4)|urinary_tract(4) 153 all_cancers(1;0.127)|Ovarian(82;0.0177)|Myeloproliferative disorder(862;0.194) UCEC - Uterine corpus endometrioid carcinoma (126;0.121)|OV - Ovarian serous cystadenocarcinoma(56;9.65e-15) CACAGCCACCGACCTGGCCCC 0.667000 93 48 0 0 1 0 0 NNMT 4837 broad.mit.edu 37 11 114182852 114182852 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:114182852G>A ENST00000535401.1 + 5 712 c.448G>A c.(448-450)Ggg>Agg p.G150R NNMT_ENST00000299964.3_Missense_Mutation_p.G150R|NNMT_ENST00000542647.1_5'UTR|RP11-64D24.2_ENST00000544925.1_RNA|NNMT_ENST00000545255.1_5'UTR|NNMT_ENST00000541754.1_5'UTR P40261 NNMT_HUMAN nicotinamide N-methyltransferase 150 xenobiotic metabolic process cytosol nicotinamide N-methyltransferase activity|pyridine N-methyltransferase activity kidney(1)|large_intestine(4)|lung(8)|ovary(1)|skin(1)|upper_aerodigestive_tract(1) 16 all_cancers(61;4.83e-16)|all_epithelial(67;7.28e-09)|all_hematologic(158;0.000135)|Melanoma(852;0.000902)|Acute lymphoblastic leukemia(157;0.000967)|Breast(348;0.0101)|all_neural(223;0.0281)|Medulloblastoma(222;0.0425)|Prostate(24;0.0906) BRCA - Breast invasive adenocarcinoma(274;2.79e-06)|Epithelial(105;1.32e-05)|all cancers(92;0.000144)|OV - Ovarian serous cystadenocarcinoma(223;0.128) Niacin(DB00627) CCAGCCACTGGGGGCCGTCCC 0.602000 82 71 0 0 1 0 0 OR4X2 119764 broad.mit.edu 37 11 48267032 48267032 + Missense_Mutation SNP C C G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:48267032C>G ENST00000302329.3 + 1 425 c.377C>G c.(376-378)aCc>aGc p.T126S NM_001004727.1 NP_001004727.1 Q8NGF9 OR4X2_HUMAN olfactory receptor, family 4, subfamily X, member 2 126 sensory perception of smell integral to membrane|plasma membrane olfactory receptor activity breast(1)|large_intestine(4)|lung(12)|pancreas(1)|stomach(1)|upper_aerodigestive_tract(1) 20 AGCTACACCACCATCATGAAC 0.498000 6 87 0 0 1 0 0 IRF8 3394 broad.mit.edu 37 16 85952180 85952180 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr16:85952180G>A ENST00000268638.5 + 7 1181 c.759G>A c.(757-759)ccG>ccA p.P253P IRF8_ENST00000562492.1_Silent_p.P49P NM_002163.2 NP_002154.1 Q02556 IRF8_HUMAN interferon regulatory factor 8 253 interferon-gamma-mediated signaling pathway|negative regulation of transcription from RNA polymerase II promoter|type I interferon-mediated signaling pathway nucleus DNA binding|sequence-specific enhancer binding RNA polymerase II transcription factor activity breast(2)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(5)|large_intestine(2)|lung(8)|ovary(2)|prostate(1)|urinary_tract(1) 24 Prostate(104;0.0771) TGCGCTTCCCGCCGGCCGACG 0.741000 14 5 0 0 1 0 0 FAM212B 55924 broad.mit.edu 37 1 112270041 112270041 + Missense_Mutation SNP C C T rs142952172 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr1:112270041C>T ENST00000357260.5 - 2 624 c.443G>A c.(442-444)cGg>cAg p.R148Q FAM212B_ENST00000534365.1_Intron|FAM212B_ENST00000444059.2_Missense_Mutation_p.R133Q NM_019099.4 NP_061972.1 Q9NTI7 CA183_HUMAN family with sequence similarity 212, member B 148 cervix(1)|endometrium(1) 2 ATTCCGGCCCCGGGACATCAA 0.587000 34 37 0 0 1 0 0 ZFAND2B 130617 broad.mit.edu 37 2 220072487 220072487 + Missense_Mutation SNP C C G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:220072487C>G ENST00000409594.1 + 3 463 c.268C>G c.(268-270)Cag>Gag p.Q90E ZFAND2B_ENST00000409412.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000409217.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000409336.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000409097.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000409319.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000409206.1_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000468301.1_3'UTR|ZFAND2B_ENST00000444522.2_Missense_Mutation_p.Q90E|ZFAND2B_ENST00000289528.5_Missense_Mutation_p.Q90E Q8WV99 ZFN2B_HUMAN zinc finger, AN1-type domain 2B 90 endoplasmic reticulum protein binding|zinc ion binding endometrium(2)|kidney(4)|lung(4)|upper_aerodigestive_tract(1) 11 Renal(207;0.0915) Epithelial(149;1.16e-06)|all cancers(144;0.000191)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00942) TGATCCAGCACAGCAAAAACG 0.557000 10 82 0 0 1 0 0 UHRF1BP1 54887 broad.mit.edu 37 6 34827130 34827130 + Silent SNP G G A rs73419681 by1000genomes TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:34827130G>A ENST00000192788.5 + 14 3168 c.2997G>A c.(2995-2997)gaG>gaA p.E999E UHRF1BP1_ENST00000452449.2_Silent_p.E999E NM_017754.3 NP_060224.3 Q6BDS2 URFB1_HUMAN UHRF1 binding protein 1 999 breast(1)|cervix(1)|endometrium(4)|kidney(3)|large_intestine(11)|lung(24)|ovary(3)|prostate(4)|skin(1)|upper_aerodigestive_tract(2) 54 CTGGCAGGGAGACTGCTGTGA 0.552000 30 48 0 0 1 0 0 ADAR 103 broad.mit.edu 37 1 154574313 154574313 + Missense_Mutation SNP A A C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr1:154574313A>C ENST00000368474.4 - 2 1004 c.805T>G c.(805-807)Tcc>Gcc p.S269A ADAR_ENST00000292205.5_Missense_Mutation_p.S312A|ADAR_ENST00000368471.3_5'UTR NM_001111.4|NM_015840.3|NM_015841.3 NP_001102.2|NP_056655.2|NP_056656.2 P55265 DSRAD_HUMAN adenosine deaminase, RNA-specific 269 adenosine to inosine editing|gene silencing by RNA|mRNA modification|mRNA processing|type I interferon-mediated signaling pathway cytoplasm|nucleolus|nucleoplasm DNA binding|double-stranded RNA adenosine deaminase activity|metal ion binding NS(1)|breast(2)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(9)|lung(20)|ovary(4)|prostate(2)|skin(2) 51 all_lung(78;2.22e-29)|Lung NSC(65;3.66e-27)|all_hematologic(923;0.088)|Hepatocellular(266;0.0997) LUSC - Lung squamous cell carcinoma(543;0.185) Colorectal(1306;0.115) GAGTTTGGGGATCCTTGGCTA 0.488000 4 188 0 0 1 0 0 MGRN1 0 broad.mit.edu 37 16 4732911 4732911 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr16:4732911C>T ENST00000399577.5 + 14 1539 c.1446C>T c.(1444-1446)ggC>ggT p.G482G MGRN1_ENST00000415496.1_Silent_p.G461G|MGRN1_ENST00000586183.1_Silent_p.G460G|MGRN1_ENST00000588994.1_Silent_p.G460G|MGRN1_ENST00000262370.7_Silent_p.G482G NM_001142290.2 NP_001135762.1 O60291 MGRN1_HUMAN mahogunin ring finger 1, E3 ubiquitin protein ligase 482 endosome to lysosome transport|negative regulation of cAMP-mediated signaling|negative regulation of G-protein coupled receptor protein signaling pathway|protein monoubiquitination cytosol|early endosome|nucleus|plasma membrane protein binding|ubiquitin-protein ligase activity|zinc ion binding endometrium(3)|kidney(1)|large_intestine(2)|lung(4)|ovary(3)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(2) 18 CACTGGGTGGCGCAGAGCTGG 0.701000 12 13 0 0 1 0 0 NBPF10 100132406 broad.mit.edu 37 1 145367767 145367767 + Missense_Mutation SNP G G A rs77484671 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr1:145367767G>A ENST00000342960.5 + 83 10398 c.10363G>A c.(10363-10365)Gaa>Aaa p.E3455K NBPF10_ENST00000369338.1_Intron|NBPF10_ENST00000369339.2_Intron NM_001039703.4 NP_001034792.4 A6NDV3 A6NDV3_HUMAN neuroblastoma breakpoint family, member 10 3455 p.E3455K(5) NS(3)|breast(1)|central_nervous_system(3)|endometrium(12)|kidney(23)|lung(15)|ovary(1)|prostate(7)|skin(6)|urinary_tract(2) 73 all_hematologic(923;0.032) Colorectal(1306;1.36e-07)|KIRC - Kidney renal clear cell carcinoma(1967;0.00258) atcaaagaaggaaagaagaag 0.423000 3 38 0 0 1 0 0 MUC16 94025 broad.mit.edu 37 19 9062722 9062722 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:9062722T>C ENST00000397910.4 - 3 24927 c.24724A>G c.(24724-24726)Acc>Gcc p.T8242A NM_024690.2 NP_078966.2 Q8WXI7 MUC16_HUMAN mucin 16, cell surface associated 8244 Ser-rich.|Thr-rich. cell adhesion extracellular space|extrinsic to membrane|integral to membrane|plasma membrane protein binding NS(9)|autonomic_ganglia(1)|breast(26)|central_nervous_system(11)|cervix(1)|endometrium(46)|haematopoietic_and_lymphoid_tissue(5)|kidney(35)|large_intestine(91)|liver(1)|lung(278)|ovary(17)|pancreas(2)|prostate(17)|skin(18)|soft_tissue(1)|stomach(8)|upper_aerodigestive_tract(16)|urinary_tract(7) 590 ACAAGAGTGGTCATCTCTGAG 0.498000 26 25 0 0 1 0 0 CCDC155 147872 broad.mit.edu 37 19 49898432 49898432 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:49898432G>A ENST00000447857.3 + 4 423 c.218G>A c.(217-219)cGc>cAc p.R73H NM_144688.4 NP_653289.3 Q8N6L0 CC155_HUMAN coiled-coil domain containing 155 73 integral to membrane calcium ion binding NS(1)|central_nervous_system(1)|endometrium(2)|kidney(4)|large_intestine(2)|lung(10)|ovary(1)|stomach(1) 22 CAGGATGCACGCCTCCAAACA 0.622000 5 47 0 0 1 0 0 CPSF7 79869 broad.mit.edu 37 11 61178544 61178544 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:61178544G>A ENST00000340437.4 - 9 1496 c.1416C>T c.(1414-1416)agC>agT p.S472S CPSF7_ENST00000394888.4_Silent_p.S429S|CPSF7_ENST00000448745.1_Silent_p.S420S|CPSF7_ENST00000439958.3_Silent_p.S420S NM_024811.3 NP_079087.3 Q8N684 CPSF7_HUMAN cleavage and polyadenylation specific factor 7, 59kDa 429 mRNA 3'-end processing|nuclear mRNA splicing, via spliceosome|protein tetramerization|termination of RNA polymerase II transcription mRNA cleavage factor complex nucleotide binding|protein binding|RNA binding breast(3)|central_nervous_system(1)|cervix(2)|endometrium(1)|kidney(2)|large_intestine(5)|lung(5)|skin(2)|upper_aerodigestive_tract(1) 22 CCCGGGACCGGCTAGGTGACC 0.502000 46 68 0 0 1 0 0 C20orf194 25943 broad.mit.edu 37 20 3356865 3356865 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr20:3356865T>C ENST00000252032.9 - 4 435 c.368A>G c.(367-369)cAt>cGt p.H123R NM_001009984.2 NP_001009984.1 Q5TEA3 CT194_HUMAN chromosome 20 open reading frame 194 123 NS(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(11)|lung(15)|prostate(2)|skin(1) 39 ATTTCTCCAATGTGCCACATA 0.368000 35 27 0 0 1 0 0 TP53 7157 broad.mit.edu 37 17 7578263 7578263 + Nonsense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr17:7578263G>A ENST00000420246.2 - 6 718 c.586C>T c.(586-588)Cga>Tga p.R196* TP53_ENST00000359597.4_Nonsense_Mutation_p.R196*|TP53_ENST00000455263.2_Nonsense_Mutation_p.R196*|TP53_ENST00000574684.1_Intron|TP53_ENST00000413465.2_Nonsense_Mutation_p.R196*|TP53_ENST00000445888.2_Nonsense_Mutation_p.R196*|TP53_ENST00000269305.4_Nonsense_Mutation_p.R196* NM_001126114.2|NM_001276696.1 NP_001119586.1|NP_001263625.1 P04637 P53_HUMAN tumor protein p53 196 Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42. R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in LFS; germline mutation and in sporadic cancers; somatic mutation).|R -> Q (in sporadic cancers; somatic mutation).|R -> S (in a sporadic cancer; somatic mutation). activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding p.R196*(167)|p.R64*(14)|p.R103*(14)|p.0?(8)|p.R196fs*51(7)|p.?(5)|p.A189_V197delAPPQHLIRV(4)|p.P191_E198>Q(3)|p.R196R(2)|p.I195fs*50(1)|p.R64fs*>27(1)|p.R103fs*51(1)|p.P191fs*6(1)|p.I195_G199delIRVEG(1)|p.P98_E105>Q(1)|p.I195fs*12(1)|p.P59_E66>Q(1) NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79) 24185 all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081) GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174) CCTTCCACTCGGATAAGATGC 0.552000 111 """Mis, N, F""" """breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types""" """breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types""" Other conserved DNA damage response genes Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019) 24 38 0 0 1 0 0 PCLO 27445 broad.mit.edu 37 7 82580131 82580131 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:82580131T>C ENST00000423517.2 - 6 10110 c.9773A>G c.(9772-9774)gAg>gGg p.E3258G PCLO_ENST00000333891.8_Missense_Mutation_p.E3258G NM_014510.2 NP_055325.2 Q9Y6V0 PCLO_HUMAN piccolo presynaptic cytomatrix protein 3189 cytoskeleton organization|synaptic vesicle exocytosis cell junction|cytoskeleton|synaptic vesicle calcium ion binding|calcium-dependent phospholipid binding|profilin binding|transporter activity breast(3)|central_nervous_system(3)|cervix(5)|endometrium(19)|haematopoietic_and_lymphoid_tissue(3)|kidney(19)|large_intestine(35)|lung(145)|ovary(7)|prostate(4)|upper_aerodigestive_tract(14)|urinary_tract(2) 259 CTGCAGCTCCTCCAACTTTTT 0.453000 10 136 0 0 1 0 0 ACAD9 28976 broad.mit.edu 37 3 128628194 128628194 + Missense_Mutation SNP C C G TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr3:128628194C>G ENST00000308982.7 + 15 1574 c.1493C>G c.(1492-1494)gCc>gGc p.A498G ACAD9_ENST00000511526.1_3'UTR NM_014049.4 NP_054768.2 Q9H845 ACAD9_HUMAN acyl-CoA dehydrogenase family, member 9 498 mitochondrion acyl-CoA dehydrogenase activity|flavin adenine dinucleotide binding central_nervous_system(1)|endometrium(1)|large_intestine(7)|lung(12)|ovary(3)|prostate(1)|skin(3)|stomach(1)|upper_aerodigestive_tract(1) 30 TAGGACAGTGCCAACAAGTTT 0.587000 41 86 0 0 1 0 0 HKR1 284459 broad.mit.edu 37 19 37838730 37838730 + Missense_Mutation SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr19:37838730C>T ENST00000324411.4 + 5 538 c.269C>T c.(268-270)gCg>gTg p.A90V HKR1_ENST00000589392.1_Missense_Mutation_p.A71V|HKR1_ENST00000541583.2_Missense_Mutation_p.A29V|HKR1_ENST00000591134.1_Missense_Mutation_p.A29V|HKR1_ENST00000591417.1_Missense_Mutation_p.A29V|HKR1_ENST00000591259.1_Missense_Mutation_p.A71V|HKR1_ENST00000586897.1_Missense_Mutation_p.A29V|HKR1_ENST00000592168.1_Missense_Mutation_p.A29V|HKR1_ENST00000544914.1_5'UTR|HKR1_ENST00000392153.3_Missense_Mutation_p.A71V|HKR1_ENST00000591471.1_5'UTR NM_181786.2 NP_861451.1 P10072 HKR1_HUMAN HKR1, GLI-Kruppel zinc finger family member 90 KRAB. multicellular organismal development|regulation of transcription, DNA-dependent|transcription, DNA-dependent nucleus DNA binding|zinc ion binding cervix(1)|endometrium(3)|kidney(2)|large_intestine(10)|lung(9)|ovary(2)|skin(1)|upper_aerodigestive_tract(1) 29 COAD - Colon adenocarcinoma(19;0.114)|Colorectal(19;0.177) CGAGGGGAAGCGCCCTGGAGA 0.493000 3 52 0 0 1 0 0 LRP2 4036 broad.mit.edu 37 2 170030513 170030513 + Missense_Mutation SNP T T C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:170030513T>C ENST00000263816.3 - 56 11215 c.10930A>G c.(10930-10932)Aat>Gat p.N3644D NM_004525.2 NP_004516.2 P98164 LRP2_HUMAN low density lipoprotein receptor-related protein 2 3644 LDL-receptor class A 29. hormone biosynthetic process|protein glycosylation|receptor-mediated endocytosis|vitamin D metabolic process coated pit|integral to membrane|lysosome calcium ion binding|receptor activity|SH3 domain binding biliary_tract(1)|breast(16)|central_nervous_system(6)|cervix(2)|endometrium(24)|haematopoietic_and_lymphoid_tissue(2)|kidney(17)|large_intestine(70)|liver(1)|lung(117)|ovary(19)|pancreas(1)|prostate(2)|skin(17)|upper_aerodigestive_tract(7)|urinary_tract(13) 315 STAD - Stomach adenocarcinoma(1183;0.000766)|COAD - Colon adenocarcinoma(177;0.0101) Gentamicin(DB00798)|Insulin Glargine recombinant(DB00047)|Insulin Lyspro recombinant(DB00046)|Insulin recombinant(DB00030)|Insulin, porcine(DB00071)|Urokinase(DB00013) CAGCGGCCATTAGCACACCGA 0.542000 33 45 0 0 1 0 0 PKD1L1 168507 broad.mit.edu 37 7 47897211 47897211 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:47897211G>A ENST00000289672.2 - 28 4632 c.4582C>T c.(4582-4584)Cct>Tct p.P1528S NM_138295.3 NP_612152.1 Q8TDX9 PK1L1_HUMAN polycystic kidney disease 1 like 1 1528 REJ. cell-cell adhesion integral to membrane BBS9/PKD1L1(2) NS(1)|breast(9)|central_nervous_system(1)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(2)|kidney(7)|large_intestine(27)|lung(44)|ovary(12)|prostate(5)|skin(8)|stomach(4)|upper_aerodigestive_tract(5) 142 ACCTGCCCAGGAGCTTGGCTC 0.493000 14 15 0 0 1 0 0 GATA3 2625 broad.mit.edu 37 10 8100386 8100386 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr10:8100386G>A ENST00000379328.3 + 3 928 c.360G>A c.(358-360)acG>acA p.T120T GATA3_ENST00000461472.1_3'UTR|GATA3_ENST00000346208.3_Silent_p.T120T NM_001002295.1|NM_002051.2 NP_001002295.1|NP_002042.1 P23771 GATA3_HUMAN GATA binding protein 3 120 aortic valve morphogenesis|blood coagulation|canonical Wnt receptor signaling pathway involved in metanephric kidney development|cardiac right ventricle morphogenesis|cell fate determination|cellular response to interferon-alpha|cellular response to interleukin-4|cellular response to tumor necrosis factor|defense response|ear development|lymphocyte migration|male gonad development|mesenchymal to epithelial transition|mesonephros development|negative regulation of cell cycle|negative regulation of cell motility|negative regulation of cell proliferation involved in mesonephros development|negative regulation of endothelial cell apoptosis|negative regulation of fat cell differentiation|negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation|negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation|negative regulation of inflammatory response|negative regulation of mammary gland epithelial cell proliferation|nephric duct formation|norepinephrine biosynthetic process|pharyngeal system development|phosphatidylinositol 3-kinase cascade|positive regulation of endothelial cell migration|positive regulation of interleukin-13 secretion|positive regulation of interleukin-4 production|positive regulation of interleukin-5 secretion|positive regulation of protein kinase B signaling cascade|positive regulation of T cell differentiation|positive regulation of thyroid hormone generation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of transcription regulatory region DNA binding|positive regulation of ureteric bud formation|regulation of cellular response to X-ray|regulation of cytokine biosynthetic process|regulation of nephron tubule epithelial cell differentiation|response to estrogen stimulus|response to virus|sympathetic nervous system development|T cell receptor signaling pathway|TOR signaling cascade|ureteric bud formation|uterus development|ventricular septum development nuclear chromatin|nucleolus|nucleoplasm core promoter proximal region sequence-specific DNA binding|core promoter sequence-specific DNA binding|E-box binding|HMG box domain binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription|transcription coactivator activity|transcription factor binding|zinc ion binding p.T120T(1) NS(1)|breast(44)|central_nervous_system(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(6)|lung(24)|ovary(3)|skin(2) 87 TCTCCAAGACGTCCATCCACC 0.697000 """F, N, S""" breast """HDR syndrome (HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE)""" 75 117 0 0 1 0 0 AADACL2 344752 broad.mit.edu 37 3 151461908 151461908 + Missense_Mutation SNP G G C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr3:151461908G>C ENST00000356517.3 + 3 498 c.389G>C c.(388-390)aGa>aCa p.R130T NM_207365.3 NP_997248.2 Q6P093 ADCL2_HUMAN arylacetamide deacetylase-like 2 130 extracellular region|integral to membrane carboxylesterase activity NS(1)|breast(1)|endometrium(2)|large_intestine(4)|liver(1)|lung(13)|skin(2) 24 LUSC - Lung squamous cell carcinoma(72;0.0394)|Lung(72;0.0813) TTCCTGAATAGATGGACGGCA 0.358000 41 58 0 0 1 0 0 TEKT4 150483 broad.mit.edu 37 2 95542422 95542422 + Missense_Mutation SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr2:95542422G>A ENST00000295201.4 + 6 1353 c.1216G>A c.(1216-1218)Gcc>Acc p.A406T AC097374.2_ENST00000568768.1_RNA NM_144705.2 NP_653306.1 Q8WW24 TEKT4_HUMAN tektin 4 406 cell projection organization|microtubule cytoskeleton organization cilium axoneme|flagellar axoneme|microtubule p.A406P(1) NS(1)|breast(1)|endometrium(2)|kidney(2)|large_intestine(3)|lung(15)|ovary(1)|skin(2)|upper_aerodigestive_tract(1) 28 GGACATTGCCGCCATGACCAA 0.592000 18 34 0 0 1 0 0 TYR 7299 broad.mit.edu 37 11 88961080 88961080 + Missense_Mutation SNP C C G rs61754389 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:88961080C>G ENST00000263321.5 + 3 1628 c.1126C>G c.(1126-1128)Cag>Gag p.Q376E NM_000372.4 NP_000363.1 P14679 TYRO_HUMAN tyrosinase 376 TMSQVQ -> HVPGT (in Ref. 2; AAA61241). eye pigment biosynthetic process|melanin biosynthetic process from tyrosine|visual perception Golgi-associated vesicle|integral to membrane|lysosome|melanosome membrane|perinuclear region of cytoplasm copper ion binding|monophenol monooxygenase activity|protein heterodimerization activity|protein homodimerization activity breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(25)|ovary(2)|pancreas(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1) 48 Acute lymphoblastic leukemia(157;2.33e-05)|all_hematologic(158;0.0033) Azelaic Acid(DB00548)|Mimosine(DB01055)|NADH(DB00157) AACAATGTCCCAGGTACAGGG 0.413000 15 103 0 0 1 0 0 FRMD4A 55691 broad.mit.edu 37 10 13698931 13698931 + Silent SNP G G A TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr10:13698931G>A ENST00000357447.2 - 22 3026 c.2658C>T c.(2656-2658)ggC>ggT p.G886G FRMD4A_ENST00000358621.4_Silent_p.G871G|FRMD4A_ENST00000378503.1_Silent_p.G886G NM_018027.3 NP_060497.3 Q9P2Q2 FRM4A_HUMAN FERM domain containing 4A 886 cytoplasm|cytoskeleton binding breast(4)|endometrium(9)|kidney(2)|large_intestine(11)|lung(9)|ovary(2)|pancreas(1)|prostate(2)|skin(1) 41 CGTCGCCGCCGCCGCCGCGCC 0.716000 4 8 0 0 1 0 0 IGDCC4 57722 broad.mit.edu 37 15 65684524 65684524 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr15:65684524C>T ENST00000352385.2 - 11 2279 c.2070G>A c.(2068-2070)gtG>gtA p.V690V NM_020962.1 NP_066013.1 Q8TDY8 IGDC4_HUMAN immunoglobulin superfamily, DCC subclass, member 4 690 Fibronectin type-III 3. integral to membrane|plasma membrane NS(1)|central_nervous_system(1)|endometrium(1)|large_intestine(7)|lung(24)|ovary(1)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(3) 44 GGACAGGCCCCACATCCCAAG 0.622000 52 84 0 0 1 0 0 NCOA6 23054 broad.mit.edu 37 20 33345744 33345744 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr20:33345744C>T ENST00000374796.2 - 8 3377 c.807G>A c.(805-807)caG>caA p.Q269Q NCOA6_ENST00000359003.2_Silent_p.Q269Q Q14686 NCOA6_HUMAN nuclear receptor coactivator 6 269 CREBBP-binding region.|Gln-rich.|NCOA1-binding region.|TBP/GTF2A-binding region. brain development|cellular lipid metabolic process|DNA recombination|DNA repair|DNA replication|estrogen receptor signaling pathway|glucocorticoid receptor signaling pathway|heart development|myeloid cell differentiation|positive regulation of transcription from RNA polymerase II promoter|response to hormone stimulus|transcription initiation from RNA polymerase II promoter transcription factor complex chromatin binding|enzyme binding|estrogen receptor binding|ligand-dependent nuclear receptor transcription coactivator activity|retinoid X receptor binding|thyroid hormone receptor binding p.Q269Q(15) NS(2)|breast(6)|central_nervous_system(3)|cervix(1)|endometrium(9)|kidney(8)|large_intestine(16)|lung(37)|ovary(4)|prostate(5)|skin(13)|upper_aerodigestive_tract(2)|urinary_tract(1) 107 gctgctgctgctgttgttgtt 0.537000 3 29 0 0 1 0 0 FASLG 356 broad.mit.edu 37 1 172634805 172634805 + Silent SNP C C A rs80358236 TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr1:172634805C>A ENST00000367721.2 + 4 679 c.495C>A c.(493-495)acC>acA p.T165T FASLG_ENST00000340030.3_3'UTR NM_000639.1 NP_000630.1 P48023 TNFL6_HUMAN Fas ligand (TNF superfamily, member 6) 165 activation of caspase activity|activation of pro-apoptotic gene products|cell-cell signaling|immune response|induction of necroptosis by extracellular signals|induction of necroptosis of activated-T cells|necrotic cell death|negative regulation of angiogenesis|positive regulation of I-kappaB kinase/NF-kappaB cascade|signal transduction extracellular space|integral to plasma membrane cytokine activity breast(1)|cervix(1)|endometrium(1)|large_intestine(2)|lung(12)|prostate(1)|skin(1) 19 GGGAAGACACCTATGGAATTG 0.428000 5 68 4.096e-09 4.22603e-09 1 1 0 CDH4 1002 broad.mit.edu 37 20 60498709 60498709 + Silent SNP G G T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr20:60498709G>T ENST00000360469.5 + 10 1663 c.1575G>T c.(1573-1575)gtG>gtT p.V525V CDH4_ENST00000543233.1_Silent_p.V451V NM_001794.3 NP_001785.2 P55283 CADH4_HUMAN cadherin 4, type 1, R-cadherin (retinal) 525 Cadherin 4. adherens junction organization|cell junction assembly calcium ion binding NS(2)|breast(2)|cervix(1)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(17)|liver(2)|lung(25)|ovary(2)|prostate(1)|skin(7)|upper_aerodigestive_tract(1)|urinary_tract(1) 74 BRCA - Breast invasive adenocarcinoma(19;2.36e-08) CCGGCACCGTGCTGACCACGT 0.622000 3 51 1 1 1 1 0 SLC20A2 6575 broad.mit.edu 37 8 42297083 42297083 + Silent SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr8:42297083C>T ENST00000342228.3 - 7 1188 c.819G>A c.(817-819)gaG>gaA p.E273E SLC20A2_ENST00000520262.1_Silent_p.E273E|SLC20A2_ENST00000520179.1_Silent_p.E273E NM_006749.4 NP_006740.1 Q08357 S20A2_HUMAN solute carrier family 20 (phosphate transporter), member 2 273 interspecies interaction between organisms integral to plasma membrane|membrane fraction inorganic phosphate transmembrane transporter activity|receptor activity|sodium-dependent phosphate transmembrane transporter activity|sodium:phosphate symporter activity breast(1)|endometrium(6)|large_intestine(5)|lung(9)|ovary(3)|prostate(1)|stomach(1) 26 all_lung(13;8.33e-12)|Lung NSC(13;1.41e-10)|Ovarian(28;0.00579)|Prostate(17;0.0119)|Lung SC(25;0.211) all_lung(54;0.00671)|Lung NSC(58;0.0184)|Esophageal squamous(32;0.131)|Hepatocellular(245;0.133)|Renal(179;0.151) BRCA - Breast invasive adenocarcinoma(8;5.73e-10)|OV - Ovarian serous cystadenocarcinoma(14;0.00419)|Lung(22;0.0302)|LUSC - Lung squamous cell carcinoma(45;0.0869) CACCTGGTAGCTCTTTAAATA 0.517000 103 140 0 0 1 0 0 GPBP1 65056 broad.mit.edu 37 5 56546841 56546841 + Nonsense_Mutation SNP C C T TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr5:56546841C>T ENST00000424459.3 + 11 2367 c.1093C>T c.(1093-1095)Cga>Tga p.R365* GPBP1_ENST00000511209.1_Nonsense_Mutation_p.R337*|GPBP1_ENST00000264779.6_Nonsense_Mutation_p.R352*|GPBP1_ENST00000506184.2_Nonsense_Mutation_p.R345*|GPBP1_ENST00000538707.1_Nonsense_Mutation_p.R352*|GPBP1_ENST00000454432.2_Nonsense_Mutation_p.R365*|GPBP1_ENST00000514387.2_Nonsense_Mutation_p.R174* NM_022913.3 NP_075064.1 Q86WP2 GPBP1_HUMAN GC-rich promoter binding protein 1 345 regulation of transcription, DNA-dependent|transcription, DNA-dependent cytoplasm|nucleus DNA binding breast(2)|central_nervous_system(1)|cervix(2)|endometrium(2)|kidney(2)|large_intestine(3)|lung(4)|ovary(1)|skin(1)|urinary_tract(1) 19 Lung NSC(810;0.000861)|Prostate(74;0.0305)|Breast(144;0.222) OV - Ovarian serous cystadenocarcinoma(10;7.64e-39) GGATATAAACCGAAACTTCGA 0.353000 15 29 0 0 1 0 0 SLC44A4 80736 broad.mit.edu 37 6 31832672 31832674 + In_Frame_Del DEL AAG AAG - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:31832672_31832674delAAG ENST00000544672.1 - 19 1913_1915 c.1617_1619delCTT c.(1615-1620)ttt>tt p.FF541del SLC44A4_ENST00000229729.6_In_Frame_Del_p.FF617del|SLC44A4_ENST00000375562.4_In_Frame_Del_p.FF575del NM_001178045.1 NP_001171516.1 Q53GD3 CTL4_HUMAN solute carrier family 44, member 4 617 integral to membrane|plasma membrane choline transmembrane transporter activity NS(1)|breast(1)|central_nervous_system(2)|cervix(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(7)|lung(11)|ovary(2)|prostate(3)|skin(1)|urinary_tract(2) 35 Choline(DB00122) GGAGAAAAAAAAGAAGGACAGGA 0.567 8 17 --- --- --- --- CASP8AP2 9994 broad.mit.edu 37 6 90565237 90565237 + RNA DEL A A - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr6:90565237delA ENST00000551025.1 + 0 1711 Q9UKL3 C8AP2_HUMAN caspase 8 associated protein 2 cell cycle|cellular response to mechanical stimulus|induction of apoptosis via death domain receptors|regulation of transcription, DNA-dependent|signal transduction|transcription, DNA-dependent cytoplasm|nucleus caspase activator activity|death receptor binding|transcription corepressor activity NS(1)|endometrium(7)|kidney(6)|large_intestine(12)|lung(21)|ovary(2)|urinary_tract(2) 51 all_cancers(76;3.64e-09)|Prostate(29;1.16e-10)|Acute lymphoblastic leukemia(125;1.45e-10)|all_hematologic(105;7.74e-07)|all_epithelial(107;4.69e-05)|Lung NSC(302;0.238) BRCA - Breast invasive adenocarcinoma(108;0.0953) AGAGCTGATGAAAAAATTTAA 0.279 2 4 --- --- --- --- FOXP2 93986 broad.mit.edu 37 7 114270016 114270018 + In_Frame_Del DEL CAG CAG - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr7:114270016_114270018delCAG ENST00000393500.3 + 11 1148_1150 c.328_330delCAG c.(328-330)del p.Q116del FOXP2_ENST00000403559.4_In_Frame_Del_p.Q208del|FOXP2_ENST00000350908.4_In_Frame_Del_p.Q191del|FOXP2_ENST00000378237.3_In_Frame_Del_p.Q191del|FOXP2_ENST00000408937.3_In_Frame_Del_p.Q216del|FOXP2_ENST00000393498.2_In_Frame_Del_p.Q171del|FOXP2_ENST00000390668.3_In_Frame_Del_p.Q215del|FOXP2_ENST00000393491.3_In_Frame_Del_p.Q99del|FOXP2_ENST00000360232.4_In_Frame_Del_p.Q191del|FOXP2_ENST00000393494.2_In_Frame_Del_p.Q191del|FOXP2_ENST00000393489.3_In_Frame_Del_p.Q99del O15409 FOXP2_HUMAN forkhead box P2 191 Gln-rich. camera-type eye development|caudate nucleus development|cerebellum development|cerebral cortex development|embryo development|growth|lung alveolus development|negative regulation of transcription, DNA-dependent|pattern specification process|positive regulation of epithelial cell proliferation involved in lung morphogenesis|positive regulation of mesenchymal cell proliferation|post-embryonic development|putamen development|regulation of sequence-specific DNA binding transcription factor activity|righting reflex|skeletal muscle tissue development|smooth muscle tissue development|vocal learning cytoplasm|transcription factor complex chromatin binding|DNA bending activity|double-stranded DNA binding|promoter binding|protein heterodimerization activity|protein homodimerization activity|sequence-specific DNA binding|sequence-specific enhancer binding RNA polymerase II transcription factor activity|specific RNA polymerase II transcription factor activity|specific transcriptional repressor activity|transcription activator activity|transcription factor binding|zinc ion binding p.Q210Q(2) breast(3)|endometrium(7)|kidney(4)|large_intestine(7)|lung(22)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2) 52 gcagcagcaacagcagcagcagc 0.507 7 70 --- --- --- --- H2AFX 3014 broad.mit.edu 37 11 118965808 118965809 + Frame_Shift_Ins INS - - C TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr11:118965808_118965809insC ENST00000530167.1 - 1 368_369 c.296_297insG c.(295-297)gggfs p.G99fs NM_002105.2 NP_002096.1 P16104 H2AX_HUMAN H2A histone family, member X 99 DNA damage checkpoint|double-strand break repair via homologous recombination|meiosis|nucleosome assembly|positive regulation of DNA repair|response to ionizing radiation nucleoplasm|nucleosome DNA binding|enzyme binding|histone binding lung(3) 3 all_hematologic(175;0.0977) Medulloblastoma(222;0.0425)|Breast(348;0.052)|all_neural(223;0.112) BRCA - Breast invasive adenocarcinoma(274;7.47e-05) TCGTCACGCCGCCCAGCAGCTT 0.693 Chromatin Structure OREG0021395 type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip) 73 191 --- --- --- --- RP11-863P13.2 0 broad.mit.edu 37 16 88226560 88226562 + RNA DEL GAG GAG - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr16:88226560_88226562delGAG ENST00000568587.1 - 0 91 tgatgatgatgaggatgatggtg 0.517 4 9 --- --- --- --- CTB-58E17.3 0 broad.mit.edu 37 17 36861701 36861703 + RNA DEL GAG GAG - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chr17:36861701_36861703delGAG ENST00000583409.1 - 0 208 CAGAGCGAGCgaggaggaggagg 0.734 3 6 --- --- --- --- ATRX 546 broad.mit.edu 37 X 76937745 76937745 + Frame_Shift_Del DEL T T - TCGA-HT-7604-01A-11D-2086-08 TCGA-HT-7604-10A-01D-2086-08 Untested Somatic Phase_I WXS none Illumina GAIIx 5211e243-bc17-4e8b-923c-8ca6cec24a7e 2d99f565-7fa6-435a-aa7a-f10f78fe5b90 g.chrX:76937745delT ENST00000373344.5 - 9 3217 c.3003delA c.(3001-3003)aafs p.K1001fs ATRX_ENST00000480283.1_5'UTR|ATRX_ENST00000395603.3_Frame_Shift_Del_p.K963fs NM_000489.3 NP_000480.2 P46100 ATRX_HUMAN alpha thalassemia/mental retardation syndrome X-linked 1001 DNA methylation|DNA recombination|DNA repair|regulation of transcription, DNA-dependent nuclear heterochromatin ATP binding|chromo shadow domain binding|DNA binding|DNA helicase activity|zinc ion binding p.?(1) bone(1)|breast(6)|central_nervous_system(31)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(15)|kidney(14)|large_intestine(1)|liver(1)|lung(40)|ovary(2)|pancreas(13)|prostate(5)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2) 145 Phosphatidylserine(DB00144) TTTTAATTACTTTTTTCTTAA 0.338 """Mis, F, N""" """Pancreatic neuroendocrine tumors, paediatric GBM""" ATR-X (alpha thalassemia/mental retardation) syndrome 52 8 --- --- --- ---